Human papillomavirus vaccines and the potential for cross-protection between related HPV types

KA Ault - Gynecologic oncology, 2007 - Elsevier
Human papillomavirus phylogenetic tree The human papillomavirus (HPV) belongs to the
papillomavirus … The genus alpha papillomavirus is most common in humans, however, the …

A study of women's knowledge regarding human papillomavirus infection, cervical cancer and human papillomavirus vaccines

M Giles, S Garland - Australian and New Zealand journal of …, 2006 - Wiley Online Library
Human papillomavirus (HPV) is the most common sexually transmitted viral infection, with
… study who did not belong to the vaccine trial group had never heard of a vaccine for HPV. …

[HTML][HTML] Current status and future prospects for human papillomavirus vaccines

HJ Kim, HJ Kim - Archives of pharmacal research, 2017 - Springer
Human papillomaviruses (HPVs) cause almost all cervical cancers in low-income countries.
Three prophylactic HPV virus-like particle-based vaccines have … to use these vaccinations. In …

[HTML][HTML] Cost-effectiveness of human papillomavirus vaccination in the United States

HW Chesson, DU Ekwueme, M Saraiya… - Emerging infectious …, 2008 - ncbi.nlm.nih.gov
… We describe a simplified model, based on the current economic and health effects of
human papillomavirus (HPV), to estimate the cost-effectiveness of HPV vaccination of 12-year-old …

[HTML][HTML] Safety, tolerability and side effects of human papillomavirus vaccines: a systematic quantitative review

AK Gonçalves, RN Cobucci, HM Rodrigues… - Brazilian Journal of …, 2014 - SciELO Brasil
human papillomavirus vaccination among adolescent girls and young women: 21 barriers to
vaccination … , followed by beliefs that vaccination was unnecessary, and concerns regarding …

Integrating clinical, community, and policy perspectives on human papillomavirus vaccination

ME Fernández, JD Allen, R Mistry… - Annual review of public …, 2010 - annualreviews.org
Infection with genital human papillomavirus (HPV) may … vaccines (a bivalent and a quadrivalent
vaccine) are now licensed and currently in use in a number of countries. Both vaccines

Potential health and economic impact of adding a human papillomavirus vaccine to screening programs

SL Kulasingam, ER Myers - Jama, 2003 - jamanetwork.com
… A controlled trial of a human papillomavirus type 16 vaccine. … Detection of human
papillomavirus DNA in cytologically … A controlled trial of a human papillomavirus type 16 vaccine. …

Physicians' human papillomavirus vaccine recommendations, 2009 and 2011

ST Vadaparampil, TL Malo, JA Kahn… - American journal of …, 2014 - Elsevier
… predictor of human papillomavirus (HPV) vaccine uptake. Understanding factors associated
with recommendation is important for efforts to increase current suboptimal vaccine uptake. …

Human papillomavirus vaccination among adults aged 18− 26, 2013− 2018

P Boersma, LI Black - 2020 - stacks.cdc.gov
… or more doses of human papillomavirus vaccine, by sex and … one or more doses of human
papillomavirus vaccine (9.1% in … age at first human papillomavirus vaccine dose among adults …

The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada

M Brisson, N Van de Velde, P De Wals, MC Boily - Vaccine, 2007 - Elsevier
human papillomavirus (HPV) vaccines to be effective against infection and disease. We
examined whether HPV vaccination … like particle vaccine against human papillomavirus types 16 …